Canada markets closed

Mabpharm Limited (2181.HK)

HKSE - HKSE Delayed Price. Currency in HKD
Add to watchlist
0.395-0.005 (-1.25%)
At close: 02:08PM HKT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
87,161
87,161
55,918
82,882
0
Cost of Revenue
11,923
11,923
15,375
16,777
0
Gross Profit
75,238
75,238
40,543
66,105
0
Operating Expenses
Research Development
123,211
123,211
147,906
263,572
120,418
Selling General and Administrative
69,943
69,943
50,182
30,714
18,560
Total Operating Expenses
273,523
273,523
239,756
350,763
163,434
Operating Income or Loss
-198,285
-198,285
-199,213
-284,658
-163,434
Interest Expense
9,578
9,578
7,188
2,403
3,942
Income Before Tax
-209,356
-209,356
-210,819
-291,744
-184,632
Income Tax Expense
0
0
0
0
0
Income from Continuing Operations
-209,356
-209,356
-210,819
-291,744
-184,632
Net Income
-209,356
-209,356
-210,819
-291,744
-184,632
Net Income available to common shareholders
-209,356
-209,356
-210,819
-291,744
-184,632
Basic EPS
-0.04
-
-0.05
-0.07
-0.04
Diluted EPS
-0.04
-
-0.05
-0.07
-0.04
Basic Average Shares
4,124,080
-
4,124,080
4,124,080
4,124,080
Diluted Average Shares
4,124,080
-
4,124,080
4,124,080
4,124,080